Cited by 89Prenatal Substance Exposure EffectsSubstance Abuse Treatment and OutcomesMaternal Mental Health During Pregnancy and Postpartum

The prevalence and impact of substance use disorder and treatment on maternal obstetric experiences and birth outcomes among singleton deliveries in Massachusetts

Open access
Kotelchuck, Milton, Cheng, Erika R., Belanoff, Candice, Cabral, Howard J., Babakhanlou-Chase, Hermik, Derrington, Taletha M., Diop, Hafsatou, Evans, Stephen R. +1 more·2017·Maternal and Child Health Journal

Abstract

Objectives Despite widely-known negative effects of substance use disorders (SUD) on women, children, and society, knowledge about population-based prevalence and impact of SUD and SUD treatment during the perinatal period is limited. Methods Population-based data from 375,851 singleton deliveries in Massachusetts 2003-2007 were drawn from a maternal-infant longitudinally-linked statewide dataset of vital statistics, hospital discharges (including emergency department (ED) visits), and SUD treatment records. Maternal SUD and SUD treatment were identified from 1-year pre-conception through delivery. We determined (1) the prevalence of SUD and SUD treatment; (2) the association of SUD with women's perinatal health service utilization, obstetric experiences, and birth outcomes; and (3) the association of SUD treatment with birth outcomes, using both bivariate and adjusted analyses. Results 5.5% of Massachusetts's deliveries between 2003 and 2007 occurred in mothers with SUD, but only 66% of them received SUD treatment pre-delivery. Women with SUD were poorer, less educated and had more health problems; utilized less prenatal care but more antenatal ED visits and hospitalizations, and had worse obstetric and birth outcomes. In adjusted analyses, SUD was associated with higher risk of prematurity (AOR 1.35, 95% CI 1.28-1.41) and low birth weight (LBW) (AOR 1.73, 95% CI 1.64-1.82). Women receiving SUD treatment had lower odds of prematurity (AOR 0.61, 95% CI 0.55-0.68) and LBW (AOR 0.54, 95% CI 0.49-0.61). Conclusions for Practice SUD treatment may improve perinatal outcomes among pregnant women with SUD, but many who need treatment don't receive it. Longitudinally-linked existing public health and programmatic records provide opportunities for states to monitor SUD identification and treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10995-016-2190-y

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pregnant individuals with comorbid PTSD/SUD are at especially high risk for adverse perinatal outcomes.

    “Pregnant individuals with comorbid PTSD and Substance Use Disorder (PTSD/SUD) are a subgroup that is at especially high risk for adverse perinatal outcomes [4,9].”

    From Written exposure therapy for treatment of perinatal PTSD among women with comorbid PTSD and SUD: A pilot study examining feasibility, acceptability, and preliminary effectiveness (2023) · cites this paper as [9]

    The Results section, “SUD and Birth Outcomes” (page unavailable), reports higher rates of low birthweight and prematurity among women with SUD. The Methods section, “Measures” (page unavailable), includes PTSD within a broad psychiatric-comorbidity variable, but the paper does not report perinatal outcomes specifically for the comorbid PTSD/SUD subgroup or establish that it is at especially high risk. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kotelchuck, M., Cheng, E. R., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., Derrington, T. M., Diop, H., Evans, S. R., & Bernstein, J.
Affiliations
  • Harvard University (US)
  • Indiana University Indianapolis (US)
  • Boston University (US)
  • SRI International (US)
  • Massachusetts Department of Public Health (US)
Corresponding author
Kotelchuck, Milton
Venue
Maternal and Child Health Journal
Published
2016-11-10
Volume
21
Issue
4
Pages
893-902
ISSN
  • 1092-7875 (ISSN-L)
  • 1573-6628
OpenAlex
W2549571577
Cited by
89
References
32
Citations by year
2026: 7 · 2025: 8 · 2024: 12 · 2023: 15 · 2022: 10 · 2021: 9 · 2020: 10 · 2019: 15 · 2018: 1 · 2017: 2
FWCI
6.97
Type
journal article
Language
en
Open access
Locations
  • Maternal and Child Health Journal (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
  • Purdue University Indianapolis (Indiana University) (submittedVersion)
Funders
  • NIH NIAAA (R21AA018395)
  • NIH NIDA (R21DA027181)
  • Massachusetts Department of Public Health Bureau of Substance Abuse Services (Supplemental funding)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
substance use disorders, prenatal drug exposure, perinatal care, obstetric outcomes, birth outcomes, preterm birth, low birth weight, antenatal care utilization, maternal health disparities
MeSH terms
Adult, Female, Humans, Infant, Low Birth Weight, Infant, Newborn, Infant, Newborn, Diseases, Longitudinal Studies, Male, Massachusetts, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Risk Factors, Prevalence, Perinatal Care, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review